State Street Corp Novartis Ag Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Novartis Ag stock. As of the latest transaction made, State Street Corp holds 1,585,485 shares of NVS stock, worth $184 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,585,485

Previous 1,640,338 3.34%

Holding current value

$184 Million

Previous $160 Million 10.73%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$97.14 - $115.57 $5.33 Million - $6.34 Million	-54,853 Reduced 3.34%	1,585,485 $177 Million
Q4 2024 Feb 14, 2025	SELL	$96.78 - $117.18 $5.32 Million - $6.44 Million	-54,971 Reduced 3.24%	1,640,338 $160 Million
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $6.23 Million - $7.09 Million	-58,665 Reduced 3.34%	1,695,309 $195 Million
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $1.48 Million - $1.72 Million	16,020 Added 0.92%	1,753,974 $187 Million
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $3.72 Million - $4.24 Million	-39,094 Reduced 2.2%	1,737,954 $168 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $1.89 Million - $2.09 Million	20,534 Added 1.17%	1,777,048 $179 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $3.25 Million - $3.61 Million	-34,349 Reduced 1.92%	1,756,514 $179 Million
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $8.11 Million - $9.19 Million	-87,608 Reduced 4.66%	1,790,863 $181 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $791,176 - $917,519	-9,886 Reduced 0.52%	1,878,471 $173 Million
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $2.94 Million - $3.6 Million	-38,920 Reduced 2.02%	1,888,357 $171 Million
Q3 2022 Nov 15, 2022	SELL	$74.61 - $87.26 $3.18 Million - $3.72 Million	-42,628 Reduced 2.16%	1,927,277 $146 Million
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $575,315 - $669,843	7,145 Added 0.36%	1,969,905 $167 Million
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $645,686 - $730,397	8,060 Added 0.41%	1,962,760 $172 Million
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $4.83 Million - $5.34 Million	-60,564 Reduced 3.01%	1,954,700 $171 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $1.98 Million - $2.3 Million	-24,225 Reduced 1.19%	2,015,264 $165 Million
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $2.79 Million - $3.08 Million	32,764 Added 1.63%	2,039,489 $186 Million
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $2.13 Million - $2.52 Million	-25,566 Reduced 1.26%	2,006,725 $172 Million
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $5.5 Million - $6.65 Million	-70,388 Reduced 3.35%	2,032,291 $192 Million
Q3 2020 Nov 10, 2020	SELL	$82.14 - $91.0 $2.59 Million - $2.87 Million	-31,565 Reduced 1.48%	2,102,679 $183 Million
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $1.44 Million - $1.62 Million	17,817 Added 0.84%	2,134,244 $186 Million
Q1 2020 May 11, 2020	BUY	$70.67 - $99.01 $150 Million - $210 Million	2,116,427 New	2,116,427 $174 Million

Others Institutions Holding NVS

# of Institutions

1,524

Shares Held

142M

Call Options Held

1.63M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Novartis Ag Transaction History